These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 4089785

  • 21. Amikacin pharmacokinetics in morbidly obese patients.
    Bauer LA, Blouin RA, Griffen WO, Record KE, Bell RM.
    Am J Hosp Pharm; 1980 Apr; 37(4):519-22. PubMed ID: 7377215
    [Abstract] [Full Text] [Related]

  • 22. Influence of the route of administration on the pharmacokinetics of amikacin.
    Lanao JM, Dominguez-Gil A, Tabernero JM, Corbacho L.
    Eur J Clin Pharmacol; 1981 Apr; 19(5):367-70. PubMed ID: 7238565
    [Abstract] [Full Text] [Related]

  • 23. [Pharmacokinetics of amikacin in burn patients of middle-degree severity].
    Vinçon G, Sanchez R, Perro G, Cutillas M, Castède JC, Masse C, Albin H.
    Therapie; 1986 Apr; 41(6):417-20. PubMed ID: 3810536
    [No Abstract] [Full Text] [Related]

  • 24. The effect of peritoneal dialysis of the pharmacokinetics of amikacin.
    Matzke GR, Salem N, Bockbrader H, Blevins R.
    Proc Clin Dial Transplant Forum; 1980 Apr; 10():302-4. PubMed ID: 7346850
    [No Abstract] [Full Text] [Related]

  • 25. Kinetics and dose calculations of amikacin in the newborn.
    Sardemann H, Colding H, Hendel J, Kampmann JP, Hvidberg EF, Vejlsgaard R.
    Clin Pharmacol Ther; 1976 Jul; 20(1):59-66. PubMed ID: 1277725
    [Abstract] [Full Text] [Related]

  • 26. [Comparison of absorption and excretion of powdery preparation for injection and liquid preparation of BB-K8 (amikacin) (author's transl)].
    Okubo H, Okamoto Y, Uba F, Ueda Y, Ueda T.
    Jpn J Antibiot; 1975 Jun; 28(3):283-7. PubMed ID: 1152282
    [No Abstract] [Full Text] [Related]

  • 27. [Metabolism and kinetics of ampicillin elimination in cirrhosis. Therapeutical consequences (author's transl)].
    Chalas J, Labayle D, Macarrio J, Barraud D, Lindenbaum A, Buffet C, Chaput JC.
    Sem Hop; 1975 Jun; 56(9-10):464-9. PubMed ID: 6244668
    [Abstract] [Full Text] [Related]

  • 28. Influence of type of dialyzer on the pharmacokinetics of amikacin.
    Lanao JM, Dominguez-Gil A, Tabernero JM, Macias JF.
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):197-202. PubMed ID: 6862725
    [Abstract] [Full Text] [Related]

  • 29. Pharmacokinetics of amikacin in infants and pre-school children.
    Kafetzis DA, Sinaniotis CA, Papadatos CJ, Kosmidis J.
    Acta Paediatr Scand; 1979 May; 68(3):419-22. PubMed ID: 443042
    [Abstract] [Full Text] [Related]

  • 30. Amikacin levels in the human biliary tract.
    LeFrock JL, Schell RF, Siskind S, Carr BB.
    J Clin Pharmacol; 1984 May; 24(5-6):247-54. PubMed ID: 6747021
    [Abstract] [Full Text] [Related]

  • 31. [Penetration of amikacin into the anterior chamber of the human eye].
    Barrera V, Sinues B, Martinez P, Buatas A, Pinero A.
    Therapie; 1985 May; 40(2):135-7. PubMed ID: 4002191
    [No Abstract] [Full Text] [Related]

  • 32. Amikacin pharmacokinetics in morbidly obese patients undergoing gastric-bypass surgery.
    Blouin RA, Brouwer KL, Record KE, Griffen WO, Plezia PM, John W.
    Clin Pharm; 1985 May; 4(1):70-2. PubMed ID: 3971686
    [No Abstract] [Full Text] [Related]

  • 33. [Pharmacological studies of amikacin (BB-K8) (author's transl)].
    Matsuzaki M, Onodera K, Okazaki I, Nakajima A, Akima T.
    Jpn J Antibiot; 1975 Jun; 28(3):385-400. PubMed ID: 1152292
    [No Abstract] [Full Text] [Related]

  • 34. Amikacin in the treatment of pyelonephritis.
    Höffler D.
    Int J Clin Pharmacol Biopharm; 1979 Oct; 17(10):386-91. PubMed ID: 387619
    [No Abstract] [Full Text] [Related]

  • 35. [Evaluation of amikacin intravenous therapy in pediatrics (author's transl)].
    Nakazawa S, Sato H, Fujii N, Kojima S, Narita A, Chikaoka H, Oka S.
    Jpn J Antibiot; 1980 Oct; 33(10):1104-10. PubMed ID: 7206214
    [No Abstract] [Full Text] [Related]

  • 36. [Studies on the toxicity of amikacin (BB-K8), I. Acute toxicity and subacute toxicity in rats (author's transl)].
    Matsuzaki M, Nakamura K, Akutsu S, Sekino M, Hirata A.
    Jpn J Antibiot; 1975 Aug; 28(4):415-34. PubMed ID: 1160141
    [No Abstract] [Full Text] [Related]

  • 37. Distribution of amikacin in serum, muscle, and fat in children after a single intramuscular injection.
    Daschner F, Reiss E, Engert J.
    Antimicrob Agents Chemother; 1977 Jun; 11(6):1081-3. PubMed ID: 879756
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics of amikacin and cephalothin in bedridden elderly patients.
    Yasuhara H, Kobayashi S, Sakamoto K, Kamijo K.
    J Clin Pharmacol; 1982 Jun; 22(8-9):403-9. PubMed ID: 7130429
    [Abstract] [Full Text] [Related]

  • 39. [Blood level of amikacin after drip intravenous infusion (author's transl)].
    Sawae Y, Takii M.
    Jpn J Antibiot; 1980 Apr; 33(4):539-48. PubMed ID: 7411857
    [No Abstract] [Full Text] [Related]

  • 40. [Peritoneal transfer of amikacin: its use in peritoneal dialysis. Preliminary study].
    Slingeneyer A, Liendo-Liendo C, Despaux E, Balmayer B, Perez C, Mion C.
    Nouv Presse Med; 1979 Oct 31; 8(42):3432-5. PubMed ID: 537890
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.